International Journal of Cardiovascular Research & Innovation

Instructions for Authors

Thank you for choosing to submit your paper to the International Journal of Cardiovascular Research & Innovation. These instructions will ensure we have everything required so that your paper can move through peer review, production, and publication smoothly. Please take time to read and follow the instructions carefully to ensure your paper matches the journal’s requirements.

Reseapro journals bring articles in all areas related to Medicine, Medical, Clinical, Dental, Nursing and many more various ongoing Topics. Reseapro welcomes the submission of manuscripts that meet the general criteria of significance and scientific excellence. Papers will be published approximately 15 days after acceptance.

Following Publisher International Linking Association, PILA, Reseapro follows the Creative Commons Attribution License and Scholars Open Access publishing policies.

Reseapro Policy Regarding the NIH Mandate
Reseapro Group will support authors by posting the published version of articles by NIH grant-holders and European or UK-based biomedical or life sciences grant holders to PubMed Central immediately after publication

Editorial Policies and process
Reseapro journals follow a progressive editorial policy that encourages researchers to submit their original research, reviews and editorial observations as articles, well supported by tables and graphic representation.

Submission
Article submissions should be done using the online Editorial Manager System or through E-mail IDs provided at the respective journal’s website.

Resubmission
When you have altered your paper in light of the peer reviewer’s comments and you have written a covering letter to the editor explaining the changes you made or refuting the reviewer’s comments, you are ready to resubmit.
Try to resubmit as soon as you can. Generally, this makes it easier to do as the paper is still fresh in your mind. The scientific world moves very quickly so you want your work published before someone else produces similar work. Once you have resubmitted you will see the status of the paper changed within a specific span of time. If you don’t see this or don’t receive any acknowledgment of your resubmission, please check with the Editorial staff and confirm the receipt of the article by the Editorial Office.

Submission Guidelines

Contents
Any manuscript submitted to Reseapro journal must be original. The manuscript, or substantial parts of it, must not be under consideration by any other journal/publisher. In any case where there is the potential for overlap or duplication transparency from the authors is mandatory. Any potentially overlapping publications should be declared on submission and, where possible, uploaded as additional files with the manuscript. Any overlapping publications should be cited. The Editors of Reseapro journals reserve the right to judge potentially overlapping or redundant publications on a case-by-case basis.

Format
Most articles published in Reseapro Journals will be organized into the following sections: Title, Authors, Affiliations, Abstract, Introduction, Methods, Results, Discussion, References, Acknowledgments, Figure legends and Table Captions. Uniformity in format will help readers and users of the journal. We recognize, however, this format is not ideal for all types of studies. If you have a manuscript that would benefit from a different format, please contact the editors to discuss this further. Although, we have no firm length restrictions for the entire manuscript or individual sections, we urge authors to present and discuss their findings concisely along with maintenance of a logical flow.    

Title
The title should be specific to the study yet concise, and should allow sensitive and specific electronic retrieval of the article. It should be comprehensible to readers outside your field. Avoid specialist abbreviations if possible. Titles should be presented in title case, meaning, all words except for prepositions, articles, and conjunctions should be capitalized. If the paper is a randomized controlled trial or a meta-analysis, this description should be in the title. Examples: “Flood Effects on Water Quality and Benthic Fauna Diversity in the Upper Chao Phraya River and the Lower Ping and Nan Rivers, Thailand”. Please also provide a brief "running head" of approximately 40 characters.

Authors and Affiliations
Provide the First names or Initials (if used), Middle names or Initials (if used), Surnames, and affiliation details including department, university or organization, city, state/province (if applicable), and country for all authors. One of the authors should be designated as the corresponding author. It is the corresponding author’s responsibility to ensure that the author list and the summary of the author contributions to the study are accurate and complete. If the article has been submitted on behalf of a consortium, all consortium members and affiliations should be listed after the Acknowledgments.

Abstract
The abstract is divided into the following four sections with these headings: Title, Background, Methods and Findings, and Conclusions. It should contain all the following elements, except for items in square brackets, which are only needed for some study types. Please use the same format for abstracts submitted as pre-submission inquiries.

Background: This section should describe clearly the rationale for the study being done. It should end with a statement of the specific study hypotheses and/or study objectives.

Methods and Findings: Describe the participants or what was studied (e.g. cell lines, patient group; be as specific as possible, including numbers studied). Describe the study design/intervention/main methods used/what was primarily being assessed e.g. primary outcome measure and, if appropriate, over what period. [If appropriate, include how many participants were assessed out of those enrolled, e.g., what was the response rate for a survey.] [If critical to the understanding of the paper, describe how results were analyzed, i.e., which specific statistical tests were used.] For the main outcomes provide a numerical result if appropriate (it nearly always is) and a measure of its precision (e.g. 95% confidence interval). Describe any adverse events or side effects.
It is always preferable that the authors describe the main limitations of the study.

Conclusions: Provide a general interpretation of the results with any important recommendations for future research. [For a clinical trial provide any trial identification numbers and names (e.g. trial registration number, protocol number or acronym).]

Introduction
The introduction should discuss the purpose of the study in the broader context. As you compose the introduction, think of readers who are not experts in this field. Include a brief review of the key literature. If there are relevant controversies or disagreements in the field, they should be mentioned so that a non-expert reader can delve into these issues further. The introduction should conclude with a brief statement of the overall aim of the experiments and a comment about whether that aim was achieved.

Methods
This section should provide enough detail for reproduction of the findings. Protocols for new methods should be included, but well-established protocols may simply be referenced. Detailed methodology or supporting information relevant to the methodology can be published on our Web site. This section should also include another section with descriptions of any statistical methods employed. These should conform to the criteria outlined by the Uniform Requirements, as follows: "Describe statistical methods with enough detail to enable a knowledgeable reader with access to the original data to verify the reported results. When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Avoid relying solely on statistical hypothesis testing, such as the use of P values, which fails to convey important quantitative information. Discuss the eligibility of research participants. Give details about randomization. Describe the methods related to success of any blinding of observations. Authors should report complications of treatment whenever necessary. It is mandatory for the authors to provide the numbers of observations. Data loss during an analysis or observation (such as dropouts from a clinical trial) should be reported by the authors. References for the design of the study and statistical methods should be provided from the standard works, when possible (with pages stated), rather than to papers in which the designs or methods were originally reported. Specify any general-use computer programs used."

Results
The results section should include all relevant positive and negative findings. The section may be divided into subsections, each with a concise subheading. Large datasets, including raw data, should be submitted as supporting files; these are published online alongside the accepted article. The results section should be written in past tense.
As outlined in the Uniform requirements, authors that present statistical data in the Results section should "...specify the statistical methods used to analyze them. Restrict tables and figures to those needed to explain the argument of the paper and to assess its support. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables. Avoid nontechnical uses of technical terms in statistics, such as “random” (which implies a randomizing device), "normal," "significant," "correlations," and "sample." Define statistical terms, abbreviations, and most symbols."

Discussion
The discussion should be concise and well argued. It should start with a brief summary of the main findings. It should include paragraphs on the generalizability, clinical relevance, strengths, and, most importantly, the limitations of the study.
You may wish to discuss the following points also. How do the conclusions affect the existing knowledge in the field? How can future research build on these observations? What are the key experiments that must be done?

References
Please use this reference guide when preparing your paper.

 

In the Text Citations	Basic Citation Format	Resources in the reference list should be cited using digits in parentheses (e.g., (1), (2)). Citations should precede terminal (e.g., periods, commas, closed quotation marks, question marks, exclamation point) and nonterminal punctuation (e.g., semicolons, colons). Reference number should not be placed in parentheses.
	Multiple Resources Cited	When citing two resources in the same callout, place them in the same parentheses and separate them with a comma.
	Author Names	The names of authors associated with a resource can be included in the running text along with a numerical citation. A numerical citation, though, should not be used as a substitute for author names. Correct Wayne and Hartley (12) write … Incorrect (12) write. The citation should immediately follow the mention of the author name(s).
	Tables and Figures	Resources cited in tables or figure legends should follow the standard format and must be included in the reference list.

 

Journal Article Format	Basic Format	Format #. Author A, Author B, Author C. Title of the article. Abbr Jrnl Title. ####;##(##):####–####. doi: ##############. Cited in: PubMed; PMID ############# [optional].
	Example	1. Duffy J, Johnsen P, Ferris M, Miller M, Leighton K, McGilvray M, et al. Safety of a meningococcal group B vaccine used in response to two university outbreaks. J Adv Surg Res.
	Book/Website/Conference Format	Format #. Author A, Author B, Author C. Title of book. # ed. City (State Abbr./Country): Publisher Name; yyyy. ### p. [optional]
	Example	2. Reichman EF. Reichman’s emergency medicine procedures. 2nd ed. J Adv Surg Res; 2019.1223p

Acknowledgments
People and those who contributed to the work, but do not fit the criteria for authors should be listed in the Acknowledgments, along with their contributions. You must also ensure that anyone named in the acknowledgments agrees to being so named.
Details of the funding sources that have supported the work should be confined to the funding statement. Do not include them in the Acknowledgments.

Funding
This section should describe sources of funding that have supported the research work. Please also describe the role of the study sponsor(s), if any, in study design; collection, analysis, and interpretation of data; writing of the paper; and decision to submit it for publication.

Competing and conflicting Interests
It is important to consider this carefully. If you don’t declare a conflict of interest and you are subsequently found to have one of your papers will lose credibility. Conversely, full disclosure of conflict of interest does not prevent a paper being published but does allow you to be open with your readers. This section should list specific competing interests associated with any of the authors. If authors declare that no competing interests exist, we will print a statement to this effect. For guidelines on what is and what is not conflict of interest have a look at https://grants.nih.gov/grants/policy/coi/

Abbreviations
Please keep abbreviations to a minimum. List all non-standard abbreviations in alphabetical order, along with their expanded form. Define them as well upon first use in the text. Non-standard abbreviations should not be used unless they appear at least three times in the text.

Nomenclature
The use of standardized nomenclature in all fields of science and medicine is an essential step toward the integration and linking of scientific information reported in published literature. We will enforce the use of correct and established nomenclature wherever possible:
We strongly encourage the use of SI units. If you do not use these exclusively, please provide the SI value in parentheses after each value.
Species names should be italicized (e.g., Homo sapiens) and the full genus and species must be written out in full, both in the title of the manuscript and at the first mention of an organism in a paper; after that, the first letter of the genus name, followed by the full species name may be used.
Genes, mutations, genotypes, and alleles should be indicated in italics. Use the recommended name by consulting the appropriate genetic nomenclature database, e.g., HUGO for human genes. It is sometimes advisable to indicate the synonyms for the gene the first time it appears in the text. Gene prefixes such as those used for oncogenes or cellular localization should be shown in roman: v-fes, c-MYC, etc.
The Recommended International Non-Proprietary Name (rINN) of drugs should be provided.

Accession Numbers
All appropriate datasets, images, and information should be deposited in public resources. Please provide the relevant accession numbers (and version numbers, if appropriate). Accession numbers should be provided in parentheses after the entity on first use. Suggested databases include, but are not limited to:

ArrayExpress
BioModels Database
Database of Interacting Proteins
DNA Data Bank of Japan [DDBJ]
EMBL Nucleotide Sequence Database
GenBank
Gene Expression Omnibus [GEO]
Protein Data Bank
UniProtKB/Swiss-Prot
ClinicalTrials.gov
In addition, as much as possible, please provide accession numbers or identifiers for all entities such as genes, proteins, mutants, diseases, etc., for which there is an entry in a public database, for example:
Ensembl
Entrez Gene
FlyBase
InterPro
Mouse Genome Database (MGD)
Online Mendelian Inheritance in Man (OMIM)
Providing accession numbers allows linking to and from established databases and integrates your article with a broader collection of scientific information.

Figures

Final figures for publication should be of high quality (1200 dpi for line art, 600 dpi for grayscale and 300 dpi for color, at the correct size upto 4MB). Figures should be supplied in one of our preferred file formats: EPS, PDF, PS, JPEG, TIFF, or Microsoft Word (DOC or DOCX) files are acceptable for figures that have been drawn in Word. For information relating to other file types, please consult our Submission of electronic artwork document.

• Upload the images in JPEG format. The file size should be within 4 MB in size while uploading.
• Figures should be numbered consecutively according to the order in which they have been first cited in the text.
• Labels, numbers, and symbols should be clear and of uniform size. The lettering for figures should be large enough to be legible after reduction to fit the width of a printed column.
• Symbols, arrows, or letters used in photomicrographs should contrast with the background and should be marked neatly with transfer type or by tissue overlay and not by pen.
• Titles and detailed explanations belong in the legends for illustrations not on the illustrations themselves.
• When graphs, scatter-grams or histograms are submitted the numerical data on which they are based should also be supplied.
• The photographs and figures should be trimmed to remove all the unwanted areas.
• If photographs of individuals are used, their pictures must be accompanied by written permission to use the photograph.
• If a figure has been published elsewhere, acknowledge the original source and submit written permission from the copyright holder to reproduce the material. A credit line should appear in the legend for such figures.
• Legends for illustrations: Type or print out legends (maximum 40 words, excluding the credit line) for illustrations using double spacing, with Arabic numerals corresponding to the illustrations. When symbols, arrows, numbers, or letters are used to identify parts of the illustrations, identify and explain each one in the legend. Explain the internal scale (magnification) and identify the method of staining in photomicrographs.
• Final figures for print production: If uploaded figures are not printable quality, publisher office may request for higher resolution images which can be sent at the time of accepting of manuscript. Send sharp, glossy, un-mounted, color photographic prints, with height of 4 inches and width of 6 inches at the time of submitting the revised manuscript. Print outs of digital photographs are not acceptable. If digital images are the only source of images, ensure that the image has minimum resolution of 300 dpi or 1800 x 1600 pixels in TIFF format. Send the images on a CD. Each figure should have a label pasted (avoid use of liquid gum for pasting) on its back indicating the number of the figure, the running title, top of the figure and the legends of the figure. Do not write the contributor/s' name/s. Do not write on the back of figures, scratch, or mark them by using paper clips.

Tables

Tables should present new information rather than duplicating what is in the text. Readers should be able to interpret the table without reference to the text. Please supply editable files.

• Tables should be self-explanatory and should not duplicate textual material.
• Tables with more than 10 columns and 25 rows are not acceptable.
• Number tables, in Arabic numerals, consecutively in the order of their first citation in the text and supply a brief title for each.
• Place explanatory matter in footnotes, not in the heading.
• Explain in footnotes all non-standard abbreviations that are used in each table.
• Obtain permission for all fully borrowed, adapted, and modified tables and provide a credit line in the footnote.
• For footnotes use the following symbols, in this sequence: *, †, ‡, §, ||, ¶, **, ††, ‡‡
• Tables with their legends should be provided at the end of the text after the references. The tables along with their number should be cited at the relevant place in the text.

Equations: If you are submitting your manuscript as a Word document, please ensure that equations are editable. More information about mathematical symbols and equations.

Units: Please use SI units (non-italicized).

Article Processing Charges
Reseapro journals is self-financed and does not receive funding from any Institution/Government. Hence, the Journals operate solely through processing charges which we receive from the authors and some Academic/Corporate sponsors. The handling fee is required to meet its maintenance. Being an Open Access Journal Group, journals do not collect subscription charges from readers that enjoy free online access to the articles. Authors are hence required to pay a fair handling fee for processing their articles. However, there are no submission charges. Authors are required to make payment only after their manuscript has been accepted for publication. Authors are required to pay a one-time Article Processing Charge (APC) of 1019 USD for their accepted articles after peer review. The APC covers the costs of peer review administration and management, professional production of articles in various formats, and dissemination of published papers through multiple platforms. We do not charge any APC for the rejected articles. Additionally, certain types of papers such as Corrections, Addendums, Retractions, and Comments are published free of charge.

Reseapro Publishing believes in providing unrestricted access to all the published articles in all of its journals through our full open access policy. This means that the articles published in our journals can be used and reused by readers, while giving proper credit to the authors. All the articles published in our journals are licensed under the Creative Commons (CC BY) license.

Author Withdrawal Policy
From time to time, an author may wish to withdraw a manuscript after submitting it.
Changing one’s mind is an author’s prerogative and an author is free to withdraw an article at no charge, as long as it is withdrawn within 7 days of its initial submission.
If you have concerns or questions about it, please contact us for further discussion. We welcome your input.

Correction Notice

A Correction notice will be issued when it is necessary to correct an error or omission, where the interpretation of the article may be impacted but the scholarly integrity or original findings remain intact.

A correction notice, where possible, should always be written and approved by all authors of the article. On very rare occasions where there is a need to correct an error made in the publication process, the journal may be required to issue a correction without the authors’ direct input. However, should this occur, the journal will make its best efforts to notify the authors.

Please note that correction requests may be subject to full review, and if queries are raised, you may be expected to supply further information before the correction is approved.

Retractions

A Retraction will be issued where a major error (e.g., in the methods or analysis) invalidates the conclusions in the article or where it appears research or publication misconduct has taken place (e.g., research without required ethical approvals, fabricated data, manipulated images, plagiarism, duplicate publication, etc.).

The decision to retract an article will be made in accordance with both journal policies and COPE guidelines.

Retractions will be considered in cases where:

• Retraction might be warranted if there is clear evidence of major errors, data fabrication, or falsification that compromise the reliability of the research findings.
• Publications should be considered for retraction if plagiarised or if the findings have been published elsewhere without proper attribution, permission, or justification.
• If a publication includes material or data used without proper authorization, or infringes on copyright, it might require retraction due to legal issues.
• Retractions might be necessary for unethical research practices, compromised peer review, or undisclosed conflicts of interest that could bias interpretation of the work or recommendations by peer reviewers.
• Notices of retraction should link to the retracted article, clearly identify it with title and authors, and be published promptly and be freely accessible to all readers.
• Retraction notices should distinctly indicate they are retractions, state who is retracting, outline the reasons for retraction, and maintain an objective tone without inflammatory language.
• Retractions are inappropriate if authorship is disputed but not the findings of the study, the main results are reliable, evidence is inconclusive, or reported conflicts of interest likely did not influence the article’s conclusions.

Article Removal

An Article Removal will be issued in rare circumstances where the problems cannot be addressed through a Retraction or Correction notice. Our journal will consider the removal of a published article in very limited circumstances where:

• The article contains content that could pose a serious risk of harm if acted upon or followed.
• The article contains content that violates the rights to privacy of a study participant.
• The article is defamatory or infringes other legal rights.
• An article is subject to a court order.

In the case of an article being removed from the journal, a removal notice will be issued in its place.

Article Reprints

You will be sent a link to order article reprints via your account in our production system. For enquiries about reprints, please contact the International Journal of Cardiovascular Research & Innovation at reprints@reseaprojournal.com. You can also order print copies of the journal issue in which your article appears.

Queries

Should you have any queries, please visit our Author Services website or contact us here @ support@reseaprojournals.com.